Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome

Annals of Pharmacotherapy

Volumn 46, Issue 7-8, 2012, Pages

  Gómez Zorrilla, Silvia ^a   Ferraz, Antonio Vallano ^b   Pedrós, Consuelo ^b   Lemus, Miguel ^a   Peña, Carmen ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Bellvitge University Hospital   (Spain)

Author keywords

Adverse effects; Drug eruptions; Drug hypersensitivity; Eosinophilia; Hepatitis; Interstitial lung disease; Levetiracetam

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; DEXAMETHASONE; ETIRACETAM; FERRITIN; LACTATE DEHYDROGENASE; PHENYTOIN;

ADULT; ARTICLE; ASTROCYTOMA; CASE REPORT; COUGHING; DRESS SYNDROME; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHIL COUNT; EYE SWELLING; FACE EDEMA; FEVER; HUMAN; HYPOXEMIA; INTRACRANIAL HYPERTENSION; LABORATORY TEST; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LUNG INFILTRATE; MACULOPAPULAR RASH; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TONIC CLONIC SEIZURE;

ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; DRUG-INDUCED LIVER INJURY; EOSINOPHILIA; FEVER; HUMANS; MALE; PIRACETAM; SYNDROME;

EID: 84872607011     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R084     Document Type: Article

References (22)

1. Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 2011;36:6-11. doi: 10.1111/j.1365-2230.2010.03967.x
2. Tohyama M, Hashimoto K. New aspects of drug-induced hypersensitivity syndrome. J Dermatol 2011;38:222-228. doi: 10.1111/j.1346-8138.2010.01176.x.
3. Durán M, Danés I. Syndrome of hypersensitivity by antiepileptic drugs. Med Clin (Barc) 2001;116:155-156.
4. Bota RG, Ligasan AP, Najdowski TG, Novac A. Acute hypersensitivity syndrome caused by valproic acid: a review of the literature and a case report. Perm J 2011;15:80-84.
5. Amante MF, Filippini AV, Cejas N, Lendoire J, Imventarza O, Parisi C. DRESS syndrome and fulminant hepatic failure induced by lamotrigine. Ann Hepatol 2009;8:75-77.
6. Roquin G, Peres M, Lerolle N, et al. First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis. Ann Pharmacother 2010;44:1998-2000. doi: 10.1345/aph.1P350
7. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011;124:588-597.
8. Bavdekar SB, Muranjan MN, Gogtay NJ, Kantharia V, Kshirsagar NA. Anticonvulsant hypersensitivity syndrome: lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment. Ann Pharmacother 2004;38:1648-1650. doi: 10.1345/aph.1E042
9. Lens S, Crespo G, Carrión JA, Miquel R, Navasa M. Severe acute hepatitis in the DRESS syndrome: report of two cases. Ann Hepatol 2010;9: 198-201.
10. Surges R, Volynski KE, Walker MC. Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited. Ther Adv Neurol Disord 2008;1:13-24. doi: 10.1177/1756285608094212
11. Ulloa CM, Towfigh A, Safdieh J. Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. Neuropsychiatr Dis Treat 2009;5:467-476.
12. Newsome SD, Xue LY, Jennings T, Castaneda GY. Levetiracetam-induced diffuse interstitial lung disease. J Child Neurol 2007;22:628-630. doi: 10.1177/0883073807302602
13. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007;156: 609-611. doi: 10.1111/j.1365.2006.07704.x
14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse reactions. Clin Pharmacol Ther 1981;30:239-245.
15. Real Decreto 1344/2007, de 11 de octubre, por el que se regula la farmacovigilancia de medicamentos de uso humano. Boletín Oficial de Estado 1/11/2007: 44631- 4460 [in Spanish]. www.boe.es/boe/dias/2007/11/01/pdfs/A44631-44640.pdf (accessed 2012 Mar 8).
16. Bocquet H, Bagot M. Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-257. doi: 10.1016/S1085-5629(96)80038-1
17. Peyriére H, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155:422-428.doi: 10.1111/j.1365-2133.2006.07284.x.
18. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007;156: 1803-1804. doi: 10.1111/j.1365-2133.2007.07807.x
19. Hirsch LI, Arif H, Nahm EA, Buchsbaum R, Resor SR, Bazil CW. Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology 2008;71:1527-15234.
20. Arif H, Buchsbaum R, Weintraub D, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007;68:1701-1709.
21. Beswick TC, Cohen JB. Dose-related levetiracetam-induced reticulated drug eruption. J Drugs Dermatol 2010;9:409-410.
22. Sultan SM, Daniels LM. Levetiracetam-induced acute generalized exanthematous pustulosis. Pharmacotherapy 2011;31:83-86.